Raptiva linked to deadly PML infection
Do you have psoriasis?
Were you treated with the drug Raptiva?
Did you suffer a brain infection?
Our firm’s Raptiva injury lawyers are investigating cases of Raptiva caused progressive multifocal leukoencephalophathy or PML. PML is a rare but deadly brain infection. Raptiva was pulled off the market on April 8, 2009 due to an increase in reports of PML infection among the users of Raptiva.
What is Raptiva?
Raptiva was a drug indicated for the treatment of Psoriasis. Psoriasis is a chronic immune-system disease which causes red, thick patches to develop on the skin. It is most common in people with diabetes, obesity, and heart disease and affects up to 7.5 million people in the United States.
FDA Issues Warnings About Raptiva
In October 2008, the FDA required Genentech to add a Black Box Warning – the strongest warning the agency can issue — on Raptiva’s packaging. The new warning was designed to alert physicians and users of the increased risks of PML from taking Raptiva. The FDA also ordered the drug’s maker to develop a medication guide and other literature for the drug’s packaging to address the risks of PML.
Withdrawal of Raptiva from the Market
On April 8, 2009, Genentech announced that it was suspending sales of Raptiva in the U.S., due to reports of people taking the drug developing PML. The company advised physicians to immediately stop prescribing Raptiva for new psoriasis patients and to contact patients currently taking the drug to determine the best course of action for treatment. The company’s phased withdrawal of the drug was expected to culminate by June 2009, when Raptiva would no longer be available.
Contact a Raptiva Injury Lawyer
If you or a loved one developed life-threatening PML or another injury after taking Raptiva, contact one of our Raptiva Injury Lawyers to protect your legal rights. Contact Potts Sadaka, LLC for a free, no-obligation review of your possible Raptiva injury case by calling 1-888-99POTTS (1-888-997-6887) or by completing our online form.
